Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-29

Clinical Trial Update: An Exploratory Study of PQ Grass 27600 SU [Phase 2, Phase 3]

View source ↗

Summary

An exploratory study of PQ Grass 27600 SU completed phases 2 and 3 for seasonal allergic rhinitis, with results posted in 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PQ Grass 27600 SU

Snippet

Sponsor: Allergy Therapeutics | Conditions: Rhinitis, Allergic, Seasonal | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-04-29